UK Pharmaceutical Sector Bracing for Regulatory Shake-Up Following Brexit Possibility

From Elza Homstedt Pell of EurActiv, pharmaceutical companies are closely watching the “Brexit” referendum for the UK to leave or stay in the European Union (EU) and how it could shake up the pharma regulators. Pell argues that the UK would lose its regulatory influence in pharma over the European Medicines Agency (EMA) if the[…]